METHOD FOR PREDICTION OF RISK OF DEVELOPING TRIPLE NEGATIVE BREAST CANCER IN WOMEN USING MOLECULAR GENETIC DATA
2024-02-19
专利权人UNIV MISIS NAT SCI & TECHNOLOGY (UMNS-C)
申请日期2024-02-19
专利号RU2830346-C1
成果简介NOVELTY - Invention relates to clinical oncology, medical genetics and molecular diagnostics, and can be used to predict the risk of triple negative breast cancer in women. DNA is recovered from peripheral venous blood. Analysis of genetic markers rs8023580 of the NR2F2 gene, rs440837 of the ZBTB10 gene, rs17496332 of the PRMT6 gene. When detecting a combination of genotypes rs8023580TT of the NR2F2 gene—rs440837AA of the ZBTB10 gene—rs17496332GG of the PRMT6 gene, high risk of developing triple negative breast cancer is predicted. USE - Medicine. ADVANTAGE - Method provides obtaining new criteria for assessing the risk of developing triple negative breast cancer in women of Russian nationality, natives of the Central Black Earth Region of the Russian Federation, based on data on polymorphic markers rs8023580 NR2F2—rs440837 ZBTB10—rs17496332 PRMT6. 1 cl, 3 dwg, 4 ex
IPC 分类号C12Q-001/6806 ; C12Q-001/6827 ; C12Q-001/686 ; C12Q-001/6876 ; C12Q-001/6886 ; G01N-033/574 ; G01N-033/58
国家俄罗斯
专业领域生物科学
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/18090
专题中国科学院新疆生态与地理研究所
作者单位
UNIV MISIS NAT SCI & TECHNOLOGY (UMNS-C)
推荐引用方式
GB/T 7714
CHURNOSOV M I,PASENOV K N,ELYKOVA A V,et al. METHOD FOR PREDICTION OF RISK OF DEVELOPING TRIPLE NEGATIVE BREAST CANCER IN WOMEN USING MOLECULAR GENETIC DATA. RU2830346-C1[P]. 2024.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。